These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36050791)
1. The role of LINC01419 in regulating the cell stemness in lung adenocarcinoma through recruiting EZH2 and regulating FBP1 expression. Chen Z; Tang W; Zhou Y; He Z Biol Direct; 2022 Sep; 17(1):23. PubMed ID: 36050791 [TBL] [Abstract][Full Text] [Related]
2. LINC01419 promotes cell proliferation and metastasis in lung adenocarcinoma via sponging miR-519b-3p to up-regulate RCCD1. Cheng Z; Hou S; Wu Y; Wang X; Sun Y; Liu B; Yuan M Biochem Biophys Res Commun; 2019 Nov; 520(1):107-114. PubMed ID: 31582214 [TBL] [Abstract][Full Text] [Related]
3. EZH2 affects malignant progression and DNA damage repair of lung adenocarcinoma cells by regulating RAI2 expression. Huang M; Ding J; Wu X; Peng X; Wu G; Peng C; Zhang H; Mao C; Huang B Mutat Res; 2022; 825():111792. PubMed ID: 35939884 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells. Liu J; Pan C; Lu R; Zhang S Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911 [TBL] [Abstract][Full Text] [Related]
5. LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK. Zhang G; Chen X; Ma L; Ding R; Zhao L; Ma F; Deng X Aging (Albany NY); 2020 Jun; 12(11):11071-11084. PubMed ID: 32522890 [TBL] [Abstract][Full Text] [Related]
6. FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma. Tang Q; Xu M; Long S; Yu Y; Ma C; Wang R; Li J; Wang X; Fang F; Han L; Wu W; Wang S J Ethnopharmacol; 2024 Jan; 318(Pt A):116646. PubMed ID: 37269912 [TBL] [Abstract][Full Text] [Related]
7. MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2. Yu H; Xu X; Zhu L; Chen S; He J J Cell Mol Med; 2024 Apr; 28(8):e18216. PubMed ID: 38652219 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MSTO2P promotes proliferation and autophagy of lung cancer cells by up-regulating EZH2 expression. Wang LJ; Sun GZ; Chen YF Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3375-3382. PubMed ID: 31081092 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000 [TBL] [Abstract][Full Text] [Related]
10. Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2. Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T Cancer Med; 2018 Nov; 7(11):5554-5566. PubMed ID: 30280514 [TBL] [Abstract][Full Text] [Related]
11. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression. Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288 [TBL] [Abstract][Full Text] [Related]
12. LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1. Liang W; Wu J; Qiu X J Transl Med; 2021 Jan; 19(1):45. PubMed ID: 33499872 [TBL] [Abstract][Full Text] [Related]
13. SPOCK2 and SPRED1 function downstream of EZH2 to impede the malignant progression of lung adenocarcinoma in vitro and in vivo. Liu Y; Fan X; Jiang C; Xu S Hum Cell; 2023 Mar; 36(2):812-821. PubMed ID: 36629984 [TBL] [Abstract][Full Text] [Related]
14. FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3. Xiong X; Lai X; Zhang J; Meng Q; Wang P; Qin S; Liu W; Wang Y; Yao Z; Wang D; Li X; Liu Z; Miao H Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 36000567 [TBL] [Abstract][Full Text] [Related]
15. m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression. Zhang H; Wang SQ; Wang L; Lin H; Zhu JB; Chen R; Li LF; Cheng YD; Duan CJ; Zhang CF Cell Death Dis; 2022 Jul; 13(7):657. PubMed ID: 35902569 [TBL] [Abstract][Full Text] [Related]
16. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis. Zhang Z; Qi D; Liu X; Kang P Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792 [TBL] [Abstract][Full Text] [Related]
17. NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression. Yang Y; Fan H; Liu H; Lou X; Xiao N; Zhang C; Chen H; Chen S; Gu H; Liu H; Wan J Cell Death Dis; 2024 Jul; 15(7):506. PubMed ID: 39013911 [TBL] [Abstract][Full Text] [Related]
18. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma. Wang Y; Mei X; Song W; Wang C; Qiu X BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617 [TBL] [Abstract][Full Text] [Related]
19. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2. Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878 [TBL] [Abstract][Full Text] [Related]